NEURODERM LTD's ticker is and the CUSIP is M74231107. A total of 15 filers reported holding NEURODERM LTD in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $14,355,000 | +664.4% | 369,029 | +421.7% | 0.00% | – |
| Q1 2017 | $1,878,000 | +19.6% | 70,736 | +0.0% | 0.00% | – |
| Q4 2016 | $1,570,000 | +585.6% | 70,729 | +471.0% | 0.00% | – |
| Q3 2016 | $229,000 | -84.5% | 12,387 | -88.1% | 0.00% | – |
| Q1 2016 | $1,473,000 | -1.1% | 104,334 | +19.5% | 0.00% | – |
| Q4 2015 | $1,489,000 | +437.5% | 87,339 | +383.8% | 0.00% | – |
| Q2 2015 | $277,000 | +89.7% | 18,051 | +65.5% | 0.00% | – |
| Q1 2015 | $146,000 | -18.4% | 10,907 | -14.5% | 0.00% | – |
| Q4 2014 | $179,000 | – | 12,754 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 261,945 | $4,466,000 | 3.96% |
| ACUTA CAPITAL PARTNERS, LLC | 477,300 | $8,138,000 | 3.89% |
| Avoro Capital Advisors LLC | 520,022 | $8,866,000 | 3.05% |
| Redmile Group, LLC | 1,589,261 | $27,097,000 | 2.03% |
| NEXTHERA CAPITAL LP | 48,000 | $818,000 | 1.16% |
| SCOPIA CAPITAL MANAGEMENT LP | 2,749,038 | $46,871,000 | 0.93% |
| SENZAR ASSET MANAGEMENT, LLC | 201,700 | $3,438,985,000 | 0.38% |
| Perceptive Advisors | 270,000 | $4,604,000 | 0.34% |
| Foresite Capital Management II, LLC | 55,779 | $951,000 | 0.32% |
| RA Capital Management | 144,671 | $2,467,000 | 0.24% |